Bioactive reinforcing bioink for hybrid bioprinting of implantable bone

The project aims to develop 'BioForceInk,' a bioactive bioink for hybrid 3D bioprinting of vascularized bone implants, enhancing mechanical strength and biological functionality for clinical applications.

Subsidie
€ 150.000
2024

Projectdetails

Introduction

3D bioprinting is an emerging technique that offers promise for fabricating implantable tissues. Despite significant advancements, the field struggles to replicate the mechanical robustness and biological complexity of native tissues, particularly in applications requiring high mechanical strength such as bone.

Project Overview

This proposal introduces 'BioForceInk,' a bioactive reinforcing bioink designed for direct bioprinting alongside a cell-laden hydrogel within a cell-conductive environment. The microparticle-based bioink is printable at room temperature and solidifies at 37°C, forming a stiff, porous scaffold within the construct.

Preliminary Studies

Our preliminary studies demonstrated its excellent printability, mechanical properties, and osteoconductive capabilities in a hybrid bioprinting context. To enhance vascularized bone differentiation in vitro and support bioprinted implant integration and bone recovery in vivo, the bioink will be enriched with osteogenic and vasculogenic factors.

Project Goals

Throughout this project, we aim to:

  1. Develop the growth factor-loaded BioForceInk.
  2. Utilize it for creating vascularized bone implants by hybrid bioprinting in tandem with cell-laden soft bioink.
  3. Evaluate the regenerative potential of the bioprinted vascularized bone implants in a critical-size bone loss model.

Collaboration and Commercialization

Additionally, we plan to test the technology with industrial partners and prepare it for commercialization by the end of the project.

Innovation and Potential

BioForceInk offers a unique combination of mechanical support and biological activity that facilitates the single-step fabrication of physiologically relevant bone implants. This innovation has the potential to significantly narrow the gap between bioprinting technology and clinical application, contributing to the development of personalized, mechanically robust, and biologically functional bone implants.

Future Applications

With its tunable properties, BioForceInk could be further adapted for bioprinting of various tissues, reflecting its broad potential across the field.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-9-2024
Einddatum28-2-2026
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • TECHNION - ISRAEL INSTITUTE OF TECHNOLOGYpenvoerder

Land(en)

Israel

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

EIC Transition

Better Bioprinting by Light-sheet Lithography

B-BRIGHTER aims to develop a novel high-speed bioprinting technology for creating complex engineered tissues, enhancing drug testing and therapeutic applications while fostering healthcare innovation.

€ 2.093.331
EIC Pathfinder

PRInted Symbiotic Materials as a dynamic platform for Living Tissues production

PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.

€ 2.805.403
ERC STG

4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels

morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.

€ 1.499.906
EIC Transition

Revolutionary silk-based bioink for 3D printing of ex vivo bone marrow models to advance drug development and personalized medicine

The SILKink project aims to develop a silk-based bioink for 3D printing bone marrow tissue models to enhance stem cell culture and advance drug development and personalized medicine.

€ 2.494.687